11

  Table of Contents




Forward Looking Statements


Some of the statements contained in this Form 10-K that are not historical facts are "forward-looking statements" which can be identified by the use of terminology such as "estimates," "projects," "plans," "believes," "expects," "anticipates," "intends," or the negative or other variations, or by discussions of strategy that involve risks and uncertainties. We urge you to be cautious of the forward-looking statements, that such statements, which are contained in this Form 10-K, reflect our current beliefs with respect to future events and involve known and unknown risks, uncertainties, and other factors affecting our operations, market growth, services, products, and licenses. No assurances can be given regarding the achievement of future results, as actual results may differ materially as a result of the risks we face, and actual events may differ from the assumptions underlying the statements that have been made regarding anticipated events. Factors that may cause actual results, our performance or achievements, or industry results, to differ materially from those contemplated by such forward-looking statements include without limitation:

1. Our ability to attract and retain management and key employees;

2. Our ability to generate customer demand for our products;

3. The intensity of competition; and

4. General economic conditions.

All written and oral forward-looking statements made in connection with this Form 10-K that are attributable to us or persons acting on our behalf are expressly qualified in their entirety by these cautionary statements. Given the uncertainties that surround such statements, you are cautioned not to place undue reliance on such forward-looking statements.





Overview



Description of Business



General Information


EOS Inc. ("we," "us," "our," or the "Company") was incorporated in the State of Nevada on April 3, 2015.

On or about November 18, 2016, the Company formed EOS INC. TAIWAN BRANCH, a Taiwanese corporation ("EITB") and the Company owns 100% of EITB.

During the year ended December 31, 2017, the Company paid the expenses of EITB in the amount of approximately $6,290. Additionally, the Company will continue to pay the expenses of EITB.

Yu-Cheng Yang, a shareholder of the Company, is the sole director of EITB. Yu-Hsiang Chia is the branch manager of EITB.

Emperor Star International Trade Co., Ltd., ("Emperor Star"), was incorporated on November 16, 2015 under the laws of Taiwan. Emperor Star is in the business of marketing and distributing various consumer products, including detergents, nutrition supplements, and skin care products.

On May 3, 2017, the Company entered into and closed a Share Purchase and Sale Agreement (the "Purchase Agreement") with Emperor Star to acquire all issued and outstanding shares of Emperor Star in consideration of $30,562 in cash. As a result of the transaction, Emperor Star became the Company's wholly owned subsidiary. Upon consummation of the transaction, the Company has assumed the business of Emperor Star and ceased to be a shell company. Yu-Hsiang Chia currently serves as the officer and director of Emperor Star.






         12

  Table of Contents



We have never been a party to any bankruptcy, receivership or similar proceeding, nor have we undergone any material reclassification, merger, consolidation, purchase or sale of a significant amount of assets not in the ordinary course of business.





General Business Overview


We market and distribute skin care products manufactured by A.C. (USA), Inc. ("A.C."), which is headquartered in the City of Industry, California and has offices in Taiwan. We market and distribute A.C. skin care products to resellers who will recognize the needs of their targeted customers in various regions in Asia, such as People's Republic of China ("PRC"), Singapore and Malaysia. We acquire the products from A.C.'s Taiwan warehouses. Our strategy is to target spas, department stores and specialty stores that sell similar skin products. As of the date of this annual report, we have sold the A.C. Products to local distributors and specialty stores.

The skin care products that we will distribute are designed to address various skin care needs. Those products include moisturizers, serums, cleansers, toners, body care, exfoliators, acne and oil correctors, facial masks, cleansing devices and sun care products. A number of those products are developed for use on particular areas of the body, such as the face or hands or around the eyes.

We believe the Company, together with its subsidiaries, distributes highly innovative personal care products and ecologically friendly cleaning products in Taiwan and plans to expand its distribution to China, Malaysia, and Thailand. Emperor Star's product line includes anti-aging products that address the key signs of aging to reinvigorate and provide youthful energy and nutrition supplements. The Company stopped the line of ecologically friendly cleaning products in 2018.

In April 2018, we, through our Emperor Star, started purchasing a type of water purifying machines from Cosminergy Hitech Development Co., Ltd. ("Cosminergy") and reselling the water purifying machines in certain Asian areas and countries. The sales generated from selling the water purifying machines for the year ended December 31, 2019 were $769,592, accounting for approximately one third of the total revenue of the said period. We ceased the sales of water purifying machines from Cosminergy in April 2019.

We commenced the sales and distribution of Calibrators in November 2019. The sales generated from selling the Calibrators for the year ended December 31, 2019 were $354,401, accounting for approximately 15% of the total revenue of the said period. We ceased the sales the Calibrators from Ultra Velocity in March 2020.

In addition, we provided inventory, membership and business management software that designed by CKS Information Co., Ltd. to our customers in the fiscal year of 2019.

Critical Accounting Policies and Estimates

Principles of Consolidation

The accompanying consolidated financial statements, including the accounts of EOS Inc. and its wholly owned subsidiaries in Taiwan, British Virgin Islands, and People's Republic of China, have been prepared in conformity with accounting principles generally accepted in the United States of America. Since the Company and Emperor Star are entities under common control prior to the acquisition of Emperor Star, the transaction is accounted for as a restructuring transaction. All the assets and liabilities of Emperor Star were transferred to the Company at their respective carrying amounts on the date of transaction. The Company has recast prior period financial statements to reflect the conveyance of Emperor Star's common shares as if the restructuring transaction had occurred as of the earliest date of the consolidated financial statements. All material intercompany accounts, transactions, and profits have been eliminated in consolidation. The nature of and effects on earnings per share (EPS) of nonrecurring intra-entity transactions involving long-term assets and liabilities is not required to be eliminated and EPS amounts have been recast to include the earnings (or losses) of the transferred net assets.






         13

  Table of Contents



The functional currency of the subsidiaries in Taiwan is the New Taiwan dollars and the subsidiary in People's Republic of China is the Chinese Yuan, or Renminbi; however, the accompanying consolidated financial statements have been translated and presented in United States Dollars ($). In the accompanying consolidated financial statements and notes, "$", "US$" and "U.S. dollars" mean United States dollars, "NT$" and "NT dollars" mean New Taiwan dollars, and "RMB" means Chinese Yuan, or Renminbi.





Use of Estimates


The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.





Classification


Certain classifications have been made to the prior year financial statements to conform to the current year presentation. The reclassification had no impact on previously reported net income nor retained earnings.





Cash and Cash Equivalents


Cash and cash equivalents include cash and all highly liquid instruments with original maturities of three months or less.





Accounts Receivable


Accounts receivable are stated at carrying value less estimates made for doubtful receivables. An allowance for impairment of trade receivables is established if the collection of a receivable becomes doubtful. Such receivable becomes doubtful when there is objective evidence that the Company will not be able to collect all amounts due according to the original terms of the receivables. Significant financial difficulties of the debtor, probability that the debtor will enter into bankruptcy or financial reorganization, and default or delinquency in payments are considered indicators that the receivable is impaired. The amount of the allowance is the difference between the asset's carrying amount and the present value of estimated future cash flows, discounted at the original effective interest rate. An impairment loss is recognized in the statement of income, as are subsequent recoveries of previous impairments.





Inventory


Inventory is stated at the lower of cost and net realizable value. Net realizable value (NRV) is defined as estimated selling prices less costs of completion, disposal, and transportation. Inventory consists mainly of finished goods held for resale. Cost is determined on a weighted average cost method. The Company periodically reviews the age and turnover of its inventory to determine whether any inventory has become obsolete or has declined in value, and incurs a charge to operations for known and anticipated inventory obsolescence.





Property and Equipment


Property and equipment is carried at cost net of accumulated depreciation. Repairs and maintenance are expensed as incurred. Expenditures that improve the functionality of the related asset or extend the useful life are capitalized. When property and equipment is retired or otherwise disposed of, the related gain or loss is included in operating income. Leasehold improvements are depreciated on the straight-line method over the shorter of the remaining lease term or estimated useful life of the asset. Depreciation is calculated on the straight-line method, including property and equipment under capital leases, generally is five years. Depreciation expense is $1,916 and $2,510 for the years ended December 31, 2019 and 2018, respectively.






         14

  Table of Contents



Impairment of Long-Lived Assets

The Company has adopted Accounting Standards Codification subtopic 360-10, Property, Plant and Equipment ("ASC 360-10"). ASC 360-10 requires that long-lived assets and certain identifiable intangibles held and used by the Company be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company evaluates its long-lived assets for impairment annually or more often if events and circumstances warrant. Events relating to recoverability may include significant unfavorable changes in business conditions, recurring losses, or a forecasted inability to achieve breakeven operating results over an extended period. The Company evaluates the recoverability of long-lived assets based upon forecasted undiscounted cash flows. Should impairment in value be indicated, the carrying value of intangible assets will be adjusted, based on estimates of future discounted cash flows resulting from the use and ultimate disposition of the asset. ASC 360-10 also requires assets to be disposed of be reported at the lower of the carrying amount or the fair value less costs to sell. Management has determined that no impairments of long-lived assets currently exist as of December 31, 2019 and 2018.

Long-term Equity Investment

The Company acquires equity investment to promote business and strategic objectives. The Company accounts for non-marketable equity and other equity investments for which the Company does not have control over the investees as:





·   Equity method investments when the Company has the ability to exercise
    significant influence, but not control, over the investee. Its proportionate
    share of the income or loss is recognized monthly and is recorded in gain
    (loss) on equity investments.

·   Non-marketable cost method investments when the equity method does not apply.



Significant judgment is required to identify whether an impairment exists in the valuation of the Company's non-marketable equity investments, and therefore the Company considers this a critical accounting estimate. Its yearly analysis considers both qualitative and quantitative factors that may have a significant impact on the investee's fair value. Qualitative analysis of its investments involves understanding the financial performance and near-term prospects of the investee, changes in general market conditions in the investee's industry or geographic area, and the management and governance structure of the investee. Quantitative assessments of the fair value of its investments are developed using the market and income approaches. The market approach includes the use of comparable financial metrics of private and public companies and recent financing rounds. The income approach includes the use of a discounted cash flow model, which requires significant estimates regarding the investees' revenue, costs, and discount rates. The Company's assessment of these factors in determining whether an impairment exists could change in the future due to new developments or changes in applied assumptions.






         15

  Table of Contents



Other-Than-Temporary Impairment

The Company's long-term equity investments are subject to a periodic impairment review. Impairments affect earnings as follows:





·   Marketable equity securities include the consideration of general market
    conditions, the duration and extent to which the fair value is below cost,
    and our ability and intent to hold the investment for a sufficient period of
    time to allow for recovery of value in the foreseeable future. The Company
    also considers specific adverse conditions related to the financial health
    of, and the business outlook for, the investee, which may include industry
    and sector performance, changes in technology, operational and financing cash
    flow factors, and changes in the investee's credit rating. The Company
    records other-than-temporary impairments on marketable equity securities and
    marketable equity method investments in gain (loss) on equity investments.

·   Non-marketable equity investments based on the Company's assessment of the
    severity and duration of the impairment, and qualitative and quantitative
    analysis of the operating performance of the investee; adverse changes in
    market conditions and the regulatory or economic environment; changes in
    operating structure or management of the investee; additional funding
    requirements; and the investee's ability to remain in business. A series of
    operating losses of an investee or other factors may indicate that a decrease
    in value of the investment has occurred that is other than temporary and that
    shall be recognized even though the decrease in value is in excess of what
    would otherwise be recognized by application of the equity method. A loss in
    value of an investment that is other than a temporary decline shall be
    recognized. Evidence of a loss in value might include, but would not
    necessarily be limited to, absence of an ability to recover the carrying
    amount of the investment or inability of the investee to sustain an earnings
    capacity that would justify the carrying amount of the investment. The
    Company records other-than-temporary impairments for non-marketable cost
    method investments and equity method investments in gain (loss) on equity
    investments.




Revenue Recognition



During the fiscal year 2018, the Company has adopted FASB Accounting Standards Codification ("ASC"), Topic 606 ("ASC 606"), Revenue from Contracts with Customers, using the modified retrospective method to all contracts that were not completed as of January 1, 2018. The Company recognized the cumulative effect of applying the new revenue standard as an adjustment to the opening balance of accumulated deficit at the beginning of 2018. The results for the Company's reporting periods beginning on and after January 1, 2018 are presented under ASC 606, while prior period amounts are not adjusted and continue to be reported under the accounting standards in effect for the prior period. Based on the Company's review of existing sales contracts as of January 1, 2018, the Company concluded that the adoption of the new guidance did not have a significant change on the Company's revenue during all periods presented.

Pursuant to ASC 606, the Company recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that the Company determines is within the scope of ASC 606, the Company performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the Company satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration the Company is entitled to in exchange for the goods or services the Company transfers to the customers. At inception of the contract, once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract, determines those that are performance obligations, and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.






         16

  Table of Contents



Merchandise sales: The Company recognizes sales revenues from merchandise sales when customers obtain control of the Company's products, which typically occurs upon delivery to customer. Merchandise sales revenues are recorded at the sales price, or "transaction price".

Software sales: The Company does not develop the software products on its own. When the Company receives a purchase order from the customer, the Company would engage with the third-party software company to customize and develop the software products. The Company recognizes software revenues upon completion of the installation and testing, and transfer the control of the software products to the customer. Software revenues are recorded at the fixed sales price, or "transaction price", pursuant to the sales contracts. The Company may also charge the customer maintenance service fees on a straight-line basis over the service period pursuant to the sales contract. The Company concluded that the performance obligation for the maintenance service is distinct. Therefore, such maintenance service revenue can be separated from other elements in the arrangement.

Trade discount and allowances: The Company generally does not provide invoice discounts on product sales to its customers for prompt payment.

Product returns: The Company generally does not provide customers with the right to return a product for a full or partial refund, a credit, or an exchange for another product.

To date, product allowance and returns have been minimal and, based on its experience, the Company believes that returns of its products will continue to be minimal.

The following tables provide details of revenue by major products and by geography.





Revenue by Major Products



For the year ended December 31, 2019:
Nutrition supplement                    $   927,149
Water purifier machine                      769,592
Automobile carbon reduction machine         354,401
Skin care product                           135,964
Software                                    102,437
   Total                                $ 2,289,543




Revenue by Geography



For the year ended December 31, 2019:
Asia Pacific                            $ 2,289,543
  Total                                 $ 2,289,543

Leases -- The Company adopted FASB Accounting Standards Codification, Topic 842, Leases ("ASC 842") using the modified retrospective approach, electing the practical expedient that allows the Company not to restate its comparative periods prior to the adoption of the standard on January 1, 2019. As such, the disclosures required under ASC 842 are not presented for periods before the date of adoption. For the comparative periods prior to adoption, the Company presented the disclosures which were required under ASC 840.






         17

  Table of Contents



The Company applied the following practical expedients in the transition to the new standard and allowed under ASC 842:





   Practical                              Description

Expedient


Reassessment of  The Company elected not to reassess, at the application date,
expired or       whether any expired or existing contracts contained leases,
existing         the lease classification for any expired or existing leases,
contracts        and the accounting for initial direct costs for any existing
                 leases.
                 The Company elected to use hindsight in determining the lease

Use of hindsight term (that is, when considering options to extend or terminate


                 the lease and to purchase the underlying asset) and in
                 assessing impairment of right-to-use assets.
Reassessment of  The Company elected not to evaluate existing or expired land
existing or      easements that were not previously accounted for as leases
expired land     under ASC 840, as allowed under the transition practical
easements        expedient. Going forward, new or modified land easements will
                 be evaluated under ASU No. 2016-02.
Separation of
lease and        Lease agreements that contain both lease and non-lease
non-lease        components are generally accounted for separately.
components
Short-term lease The Company also elected the short-term lease recognition
recognition      exemption and will not recognize ROU assets or lease
exemption        liabilities for leases with a term less than 12 months.



The new leasing standard requires recognition of leases on the consolidated balance sheets as right-of-use ("ROU") assets and lease liabilities. ROU assets represent the Company's right to use underlying assets for the lease terms and lease liabilities represent the Company's obligation to make lease payments arising from the leases. Operating lease ROU assets and operating lease liabilities are recognized based on the present value and future minimum lease payments over the lease term at commencement date. The Company's future minimum based payments used to determine the Company's lease liabilities mainly include minimum based rent payments. As most of Company's leases do not provide an implicit rate, the Company uses its estimated incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments.

The adoption of ASC 842 had no substantial impact on the Company's consolidated balance sheets. The most significant impact was the recognition of the operating lease right-of-use assets and the liability for operating leases. Accordingly, adoption of this standard resulted in the recognition of operating lease right-of-use assets of $8,235 and operating lease liabilities of $8,235 on the consolidated balance sheet as of January 1, 2019. The adoption of ASC 842 did not result in a cumulative-effect adjustment to the opening balance of retained earnings.

In addition, the adoption of the standard did not have a material impact on the Company's results of operations or cash flows. Operating lease cost is recognized as a single lease cost on a straight-line basis over the lease term and is recorded in Selling, general and administrative expenses. Variable lease payments for common area maintenance, property taxes and other operating expenses are recognized as expense in the period when the changes in facts and circumstances on which the variable lease payments are based occur.





Advertising Costs


Advertising costs are expensed at the time such advertising commences. Advertising expenses were $39,645 and $13,299 for the years ended December 31, 2019 and 2018, respectively.






         18

  Table of Contents



Post-retirement and Post-employment Benefits

The Company's subsidiaries in Taiwan adopted the government mandated defined contribution plan pursuant to the Taiwan Labor Pension Act (the "Act"). Such labor regulations require that the rate of contribution made by an employer to the Labor Pension Fund per month shall not be less than 6% of the worker's monthly salaries. Pursuant to the Act, the Company makes monthly contribution equal to 6% of employees' salaries to the employees' pension fund. The Company has no legal obligation for the benefits beyond the contributions made. The total amounts for such employee benefits, which were expensed as incurred, were $7,051 and $7,958 for the years ended December 31, 2019 and 2018, respectively. Other than the above, the Company does not provide any other post-retirement or post-employment benefits.





Fair Value Measurements


FASB ASC 820, "Fair Value Measurements" defines fair value for certain financial and nonfinancial assets and liabilities that are recorded at fair value, establishes a framework for measuring fair value and expands disclosures about fair value measurements. It requires that an entity measure its financial instruments to base fair value on exit price, maximize the use of observable units and minimize the use of unobservable inputs to determine the exit price. It establishes a hierarchy which prioritizes the inputs to valuation techniques used to measure fair value. This hierarchy increases the consistency and comparability of fair value measurements and related disclosures by maximizing the use of observable inputs and minimizing the use of unobservable inputs by requiring that observable inputs be used when available. Observable inputs are inputs that reflect the assumptions market participants would use in pricing the assets or liabilities based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company's own assumptions about the assumptions market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The hierarchy prioritizes the inputs into three broad levels based on the reliability of the inputs as follows:





    •   Level 1 - Inputs are quoted prices in active markets for identical assets
        or liabilities that the Company has the ability to access at the
        measurement date. Valuation of these instruments does not require a high
        degree of judgment as the valuations are based on quoted prices in active
        markets that are readily and regularly available.

    •   Level 2 - Inputs other than quoted prices in active markets that are
        either directly or indirectly observable as of the measurement date, such
        as quoted prices for similar assets or liabilities; quoted prices in
        markets that are not active; or other inputs that are observable or can be
        corroborated by observable market data for substantially the full term of
        the assets or liabilities.

    •   Level 3 - Valuations based on inputs that are unobservable and not
        corroborated by market data. The fair value for such assets and
        liabilities is generally determined using pricing models, discounted cash
        flow methodologies, or similar techniques that incorporate the assumptions
        a market participant would use in pricing the asset or liability.



The carrying values of certain assets and liabilities of the Company, such as cash and cash equivalents, accounts receivable, inventory, advance to suppliers, prepaid expenses, accounts payable, accrued expenses, and due to shareholders, approximate fair value because of to their relatively short maturities.






         19

  Table of Contents




Net Income Per Share


Basic income per share is computed by dividing net income by weighted average number of shares of common stock outstanding during each period. Diluted income per share is computed by dividing net income by the weighted average number of shares of common stock, common stock equivalents, and potentially dilutive securities outstanding during each period. For the years ended December, 2019 and 2018, the Company does not have any outstanding common stock equivalents; therefore, a separate computation of diluted income per share is not presented.





Income Taxes


The Company accounts for income taxes in accordance with ASC 740, Income Taxes, which requires that the Company recognize deferred tax liabilities and assets based on the differences between the financial statement carrying amounts and the tax basis of assets and liabilities, using enacted tax rates in effect in the years the differences are expected to reverse. Deferred income tax benefit (expense) results from the change in net deferred tax assets or deferred tax liabilities. A valuation allowance is recorded when, in the opinion of management, it is more likely than not that some or all of any deferred tax assets will not be realized.

Concentration of Credit Risk

Cash and cash equivalents: The Company's financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents. The Company places its cash and temporary cash investments in high quality credit institutions in Taiwan, but these investments may be in excess of the insurance limits of Taiwan Central Deposit Insurance Corporation (the "TCDIC"). The Company does not enter into financial instruments for hedging, trading or speculative purposes. Concentration of credit risk with respect to trade and notes receivables is limited due to the wide variety of customers and markets in which the Company transacts business, as well as their dispersion across many geographical areas. As of December 31, 2019, the Company had approximately $124,213 in excess of TCDIC insured limits. The Company has not experienced any losses in such accounts.

Customers: The Company performs ongoing credit evaluations of its customers' financial condition and generally requires no collateral.

For the year ended December 31, 2019, one customer accounted for more than 10% of the Company's total revenues, representing approximately 95% of its total revenues, and 99% of accounts receivable in aggregate at December 31, 2019.





                                                                         Accounts
                                             Net sales for the      receivable balance
                                                 year ended          as of December,
                 Customer                    December 31, 2019             2019
                    A                        $        2,171,766     $        2,151,192




.

For the year ended December 31, 2018, two customers accounted for more than 10%
of the Company's total revenues, represented approximately 69% and 16% of its
total revenues and 69% and 13% of accounts receivable in aggregate at December
31, 2018, respectively.



                                            Net sales for the      Accounts receivable
                                                year ended            balance as of
                Customer                    December 31, 2018       December 31, 2018
                    A                       $        1,235,203 *   $         1,263,833
                    B                       $          279,405     $           237,980



*Related party transactions (see Note 4).






         20

  Table of Contents



Suppliers: The Company purchases its inventories from various suppliers.

For the year ended December 31, 2019, four suppliers accounted for more than 10% of the Company's total net purchase, representing approximately 34%, 27%, 19% and 10% of total net purchase, and 0% of accounts payable in aggregate at December 31, 2019, respectively:





                                            Net purchase for the     Accounts payable
                                            year ended December        balance as of
                Supplier                          31, 2019           December 31, 2019
                    A                       $             96,743     $               -
                    B                       $             74,819     $               -
                    C                       $             52,505     $               -
                    D                       $             28,400     $               -




For the year ended December 31, 2018, three suppliers accounted for more than
10% of the Company's total net purchase, representing approximately 41%, 23% and
16% of total net purchase, and 0% of accounts payable in aggregate at December
31, 2018, respectively:



                                            Net purchase for the     Accounts payable
                                            year ended December        balance as of
                                                    31,                December 31,
                Supplier                            2018                   2018
                    E                       $             50,529     $               -
                    B                       $             28,371     $               -
                    F                       $             19,620     $               -



Foreign-currency Transactions

Foreign-currency transactions are recorded in New Taiwan dollars ("NTD") and Renminbi ("RMB") at the rates of exchange in effect when the transactions occur. Gains or losses resulting from the application of different foreign exchange rates when cash in foreign currency is converted into New Taiwan dollars and Renminbi, or when foreign-currency receivables or payables are settled, are credited or charged to income in the year of conversion or settlement. On the balance sheet dates, the balances of foreign-currency assets and liabilities are restated at the prevailing exchange rates and the resulting differences are charged to current income except for those foreign currencies denominated investments in shares of stock where such differences are accounted for as translation adjustments under stockholders' equity.





Translation Adjustment


The accounts of the Company's subsidiaries were maintained, and their financial statements were expressed in New Taiwan Dollar ("NTD") and Renminbi ("RMB"). Such financial statements were translated into U.S. Dollars ("$" or "USD") in accordance ASC 830, "Foreign Currency Matters", with the NTD and RMB as the functional currency. According to the Statement, all assets and liabilities are translated at the current exchange rate, common stock and additional paid-in capital are translated at the historical rates, and income statement items are translated at an average exchange rate for the period. The resulting translation adjustments are reported under accumulated other comprehensive income (loss) as a component of stockholders' equity.





Comprehensive Income (loss)


Comprehensive income (loss) includes accumulated foreign currency translation gains and losses. The Company has reported the components of comprehensive income (loss) on its consolidated statements of operations and other comprehensive income (loss).






         21

  Table of Contents



Recent Accounting Pronouncements

In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement. The ASU modifies the disclosure requirements in Topic 820, Fair Value Measurement, by removing certain disclosure requirements related to the fair value hierarchy, modifying existing disclosure requirements related to measurement uncertainty and adding new disclosure requirements, such as disclosing the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period and disclosing the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. This ASU is effective for public companies for annual reporting periods and interim periods within those annual periods beginning after December 15, 2019. The Company is currently evaluating the effect, if any, that the ASU will have on its consolidated financial statements.

In December 2019, the FASB issued ASU No. 2019-12, Simplifying the Accounting for Income Taxes, as part of its initiative to reduce complexity in accounting standards. The amendments in the ASU are effective for fiscal years beginning after December 15, 2020, including interim periods therein. Early adoption of the standard is permitted, including adoption in interim or annual periods for which financial statements have not yet been issued. The Company is currently evaluating the effect, if any, that the ASU will have on its consolidated financial statements.





Results of Operations



The following presents the consolidated results of the Company for the years ended December 31, 2019 and December 31, 2018.





Net sales


Net sales were $2,289,543 for year ended December 31, 2019, representing an increase of $511,598, or 28.77%, as compared to $1,777,945 for the year ended December 31, 2018. The increase was primarily due to the increase in sales of automobile carbon reduction machines or Calibrators of approximately $350,000, nutrition supplements of approximately $420,000 and water purifying machines of approximately $210,000, partially offset by the decrease in sales of skin care products of approximately $500,000.





Cost of sales


Cost of sales was $275,463 for the year ended December 31, 2019, representing an increase of $58,958 or 27.23%, as compared to $216,505 for the year ended December 31, 2018. Such increase was mainly due to the increase in the sales of automobile carbon reduction machines, water purifying machines and nutrition supplements, partially offset by the decrease in sales of skin care products.





Gross profit


Gross profit was $2,014,080 for the year ended December 31, 2019, compared to $1,561,440 for the same period in 2018. Gross profit as a percentage of net sales was 87.97% for the year ended December 31, 2019, compared to 87.82% in the same period in 2018. The change in gross margin was because the higher gross margin product accounted for a higher proportion of sales for the year ended December 31, 2019.

Selling, general and administrative expenses

Selling, general and administrative expenses consist primarily of office rent, salary and related costs for personnel and facilities, and professional service fees. Selling, general and administrative expenses were $905,822 for the year ended December 31, 2019, representing an increase of $358,142, or 65.39%, as compared to $547,680 for the year ended December 31, 2018. The increase in selling, general and administrative expenses was primarily attributable to the increase in payroll expenses of approximately $160,000, accounting, legal and professional fees of approximately $90,000, advertising expense of approximately $26,000 and travel of approximately $25,000.






         22

  Table of Contents




Income from operations


Income from operations was $1,108,258 for the year ended December 31, 2019 compared to income from operations of $1,013,760 for the year ended December 31 2018, representing an increase of $94,498, or 9.32%. Such increase was primarily due to the increase in sales of automobile carbon reduction machines, water purifying machines and nutrition supplements, partially offset by the decrease in sales of skin care products and the increase in selling, general and administrative expenses.





Other income (expense)



Other income (expense) was $(26,491) for the year ended December 31, 2019, reflecting a decrease of $59,851, or 179.41%, compared to $33,360 for the year December 31, 2018. The decrease was mainly attributable to the increase in loss on foreign currency exchange and the increase in loss on investment in equity securities under the equity method.





Net Income


As a result of the above factors, our net income was $1,081,767 for the year ended December 31, 2019, as compared to net income of $1,029,325 for the year ended December 31, 2018, representing an increase of $52,442, or 5.09%.

Liquidity and Capital Resources

Cash and cash equivalents were $295,594 at December 31, 2019 and $36,130 at December 31, 2018. Our total current assets were $2,819,688 at December 31, 2019, as compared to $1,927,538 at December 31, 2018. Our total current liabilities were $221,694 at December 31, 2019, as compared to $299,092 at December 31, 2018.

We had working capital of $2,597,994 at December 31, 2019, compared to working capital of $1,628,446 at December 31, 2018. The increase in working capital was primarily attributable to the increase in cash and cash equivalents, accounts receivable and advance to suppliers, and the decrease in accounts payable and due to shareholder.

Net cash provided by operating activities was $265,176 during the year ended December 31, 2019, as compared to $13,505 for the year ended December 31, 2018. The increase in net cash provided by operating activities in the amount of $251,671 was primary attributable to the increase in net income and account receivable, partially offset by the increase in advance to suppliers and security deposits and other assets, and the decrease in due to shareholders.

Net cash used in investing activities was $1,818 during the year ended December 31, 2019, as compared to $2,869 for the year ended December 31, 2018. The decrease in net cash used in investing activities in the amount of $1,051 was mainly due to the decrease in purchase of equipment.

We did not have net cash flow provided by nor used in financing activities during the year ended December 31, 2019 and 2018.

As a result of the above factors, net increase in cash and cash equivalents was $36,130 for the year ended December 31, 2019, as compared to $24,610 for the year ended December 31, 2018.

Off-Balance Sheet Arrangements

We did not have any off-balance sheet arrangements as of December 31, 2019.

© Edgar Online, source Glimpses